title: Long-term thalamic stimulation in Parkinson's disease: postmortem anatomoclinical study.
abstract: Parkinsonian tremor may be suppressed by thalamic stimulation. For an equivalent clinical efficacy, its obvious advantage over micro-thalamotomy is its reversibility. This patient experienced postural tremor at the age of 44 years and akineto-rigid syndrome 8 years later. At the age of 60 years, intrathalamic stimulation was applied over a long-term period of 43 months until death and was efficient on tremor with low stimulation. This case is the first with anatomic verification. The extent of the lesion provoked by the electrode is very small. The location of the stimulation site was in the medio-inferior part of the intermedius complex at the entrance of cerebello-thalamic fibers. The stimulation of the cerebellar afferent axons could be the cause of the clinical effect. The stimulation site corresponds to the thalamic source of the precentral and accessory motor cortex, which correlates with changes observed in our PET study showing a regional cerebral blood flow decrease in cerebellar nuclei and also in precentral and accessory motor cortex. The places and mechanisms of the effects of stimulations and lesions could be different.
authors.affiliation: Clinique Neurologique, CHRU Lille, France.
authors.forename: D
authors.initials: D
authors.lastname: Caparros-Lefebvre
authors.forename: M M
authors.initials: MM
authors.lastname: Ruchoux
authors.forename: S
authors.initials: S
authors.lastname: Blond
authors.forename: H
authors.initials: H
authors.lastname: Petit
authors.forename: G
authors.initials: G
authors.lastname: Percheron
mesh_terms: D000328:Adult; D002560:Cerebrovascular Circulation / Q000502:physiology; D004599:Electric Stimulation Therapy / Q000009:adverse effects; D004567:Electrodes, Implanted / Q000009:adverse effects; D017809:Fatal Outcome; D005911:Gliosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D008297:Male; D009069:Movement Disorders / Q000517:prevention & control*; D010300:Parkinson Disease / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy*; D013378:Substantia Nigra / Q000473:pathology; D013788:Thalamus / Q000473:pathology*; D014202:Tremor / Q000209:etiology